Multiple Mouse-protective Antibodies Directed Against Group B Streptococci. Special Reference to Antibodies Effective Against Protein Antigens

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1975 Jul 1

PMID 1097573

Citations 177

Authors

R C Lancefield

M McCarty

W N Everly

Affiliations

Soon will be listed here.

Abstract

The data presented in this paper establish the finding that multiple specific protective antibodies exist in rabbits in response to immunization with Group B streptococci. The summary in Table I indicates the serological types into which Group B streptococci have been divided on the basis of their antigenic composition. This classification is dependent upon passive protection of mice with antibodies directed against the specific antigens, and types are defined in these terms. Heretofore, it was thought that type-specific polysaccharides accounted for all such protection in Group B streptococci. Certain exceptions of cross-protection between types due to minor polysaccharide determinants soon appeared; cross-protection reactions based on protein determinants in at least two types were also discovered. The present experiments show that specific antibodies directed to either polysaccharide or protein antigens of a single strain can be protective against infection with streptococci containing these antigens.

Citing Articles

Group B streptococcus induces cellular senescence in human amnion epithelial cells through a partial interleukin-1-mediated mechanism.

Park H, Hogan K, Harris S, Chames M, Loch-Caruso R Biol Reprod. 2023; 110(2):329-338.

PMID: 37903065 PMC: 10873272. DOI: 10.1093/biolre/ioad149.

Group B Streptococcus Cas9 variants provide insight into programmable gene repression and CRISPR-Cas transcriptional effects.

Gopalakrishna K, Hillebrand G, Bhavana V, Elder J, DMello A, Tettelin H Commun Biol. 2023; 6(1):620.

PMID: 37296208 PMC: 10256743. DOI: 10.1038/s42003-023-04994-w.

Genomic characterization of emerging invasive Streptococcus agalactiae serotype VIII in Alberta, Canada.

Williams A, Croxen M, Demczuk W, Martin I, Tyrrell G Eur J Clin Microbiol Infect Dis. 2023; 42(6):747-757.

PMID: 37084119 PMC: 10120474. DOI: 10.1007/s10096-023-04606-9.

Mast cell-derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections.

Piliponsky A, Sharma K, Quach P, Brokaw A, Nguyen S, Orvis A J Clin Invest. 2022; 132(20).

PMID: 36006736 PMC: 9566924. DOI: 10.1172/JCI157999.

A Recombinant Alpha-Like Protein Subunit Vaccine (GBS-NN) Provides Protection in Murine Models of Group B Streptococcus Infection.

Brokaw A, Nguyen S, Quach P, Orvis A, Furuta A, Johansson-Lindbom B J Infect Dis. 2022; 226(1):177-187.

PMID: 35429401 PMC: 9890916. DOI: 10.1093/infdis/jiac148.

References

WILKINSON H . Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic. Infect Immun. 1975; 11(4):845-52. PMC: 415144. DOI: 10.1128/iai.11.4.845-852.1975. View

Haug R . Type classification of the group B streptococci by means of Lancefield's precipitin method. Classification of strains of bovine and human origin; isolated during the year 1971 in Norway. Nord Vet Med. 1972; 24(12):631-8. View

WILKINSON H, Eagon R . Type-specific antigens of group B type Ic streptococci. Infect Immun. 1971; 4(5):596-604. PMC: 416359. DOI: 10.1128/iai.4.5.596-604.1971. View

Pattison I, MATTHEWS P, MAXTED W . Type classification by Lancefield's precipitin method of human and bovine group-B streptococci isolated in Britain. J Pathol Bacteriol. 1955; 69(1-2):43-50. DOI: 10.1002/path.1700690108. View

MAXTED W . Occurrence of the M. substance of type 28 group A in streptococci of Lancefield groups B, C and G. J Gen Microbiol. 1949; 3(1):1-6. DOI: 10.1099/00221287-3-1-1. View

Lancefield R . A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B). J Exp Med. 2009; 59(4):441-58. PMC: 2132330. DOI: 10.1084/jem.59.4.441. View

Rotta J, Krause R, Lancefield R, Everly W, Lackland H . New approaches for the laboratory recognition of M types of group A streptococci. J Exp Med. 1971; 134(5):1298-315. PMC: 2139011. DOI: 10.1084/jem.134.5.1298. View

Russell H, Norcross N . The isolation and some physiochemical and biologic properties of the type 3 antigen of group B streptococci. J Immunol. 1972; 109(1):90-6. View

WILKINSON H, Facklam R, Wortham E . Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun. 1973; 8(2):228-35. PMC: 422837. DOI: 10.1128/iai.8.2.228-235.1973. View

10.

Lancefield R, FREIMER E . Type-specific polysaccharide antigens of group B streptococci. J Hyg (Lond). 1966; 64(2):191-203. PMC: 2134722. DOI: 10.1017/s0022172400040456. View

11.

FREIMER E . Type-specific polysaccharide antigens of group B streptococci. II. The chemical basis for serological specificity of the type II HCl antigen. J Exp Med. 1967; 125(3):381-92. PMC: 2138294. DOI: 10.1084/jem.125.3.381. View

12.

Jelinkova J . [Serological typing of group B hemolytic streptococci]. Cesk Epidemiol Mikrobiol Imunol. 1963; 12:74-80. View

13.

Lancefield R . A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI. J Exp Med. 2009; 57(4):571-95. PMC: 2132252. DOI: 10.1084/jem.57.4.571. View

14.

Lancefield R . TWO SEROLOGICAL TYPES OF GROUP B HEMOLYTIC STREPTOCOCCI WITH RELATED, BUT NOT IDENTICAL, TYPE-SPECIFIC SUBSTANCES. J Exp Med. 2009; 67(1):25-40. PMC: 2133550. DOI: 10.1084/jem.67.1.25. View